These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10254882)

  • 21. A drug utilization review program with teeth in it.
    Hosp Formul; 1977 Mar; 12(3):194-5. PubMed ID: 10235807
    [No Abstract]   [Full Text] [Related]  

  • 22. Challenges in the anticipation of biosimilars: how must a P&T committee gear up?
    Tadlock C
    Manag Care Interface; 2007 Apr; 20(4):12, 14. PubMed ID: 17536251
    [No Abstract]   [Full Text] [Related]  

  • 23. P & T Committee interview: strategies to ensure an effective formulary system.
    Riff L; Hutchinson R
    Hosp Formul; 1988 Nov; 23(11):901-4, 907-8. PubMed ID: 10290754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug utilization review by pharmacy and therapeutics committees.
    Reilly MJ
    Am J Hosp Pharm; 1973 Apr; 30(4):349-50. PubMed ID: 4697660
    [No Abstract]   [Full Text] [Related]  

  • 25. The cancer and leukemia group B pharmacology and experimental therapeutics committee: a historical perspective.
    Ratain MJ; Miller AA; McLeod HL; Venook AP; Egorin MJ; Schilsky RL
    Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3612s-6s. PubMed ID: 16740794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of a P & T Committee letter to influence dosing.
    Lipman AG
    Hosp Formul; 1987 Mar; 22(3):309, 312. PubMed ID: 10281732
    [No Abstract]   [Full Text] [Related]  

  • 27. Cost containment through P & T committee drug utilization review.
    Bender FH; DeMatteo CS
    Hosp Formul; 1984 Aug; 19(8):699-700, 705-7. PubMed ID: 10267391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predetermined standards in drug use control.
    Lipman AG
    Hosp Formul; 1979 Sep; 14(9):864. PubMed ID: 10243911
    [No Abstract]   [Full Text] [Related]  

  • 29. The evolutionary role of the pharmacy and therapeutics committee in technology assessment.
    Mehr SR
    Manag Care Interface; 2006 Jan; 19(1):42-5. PubMed ID: 16453995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Minimizing the influence of drug marketing.
    Hester FG
    Hospitals; 1990 Aug; 64(15):80. PubMed ID: 2373503
    [No Abstract]   [Full Text] [Related]  

  • 31. An approach to cost-effective antibiotic utilization.
    Venezio FR; Waitley DW
    Hosp Formul; 1988 Dec; 23 Suppl D():32-5. PubMed ID: 10312796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. P & T Committee roundtable discussion: Eastern region Pt. II.
    Fine DJ; Guild RT; Kleinmann K; Kupersmith J
    Hosp Formul; 1984 Jul; 19(7):561-4, 568-70. PubMed ID: 10267389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug usage guidelines, Part 2: Analysis of program outcome.
    Patry RA; Huber SL; Hudson HD; Godwin HN
    Hosp Formul; 1985 Jan; 20(1):57-60. PubMed ID: 10269762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Pharmacy and Therapeutics Committee Part 1: overview.
    Bender FH
    Hosp Formul; 1983 May; 18(5):517-8, 523-4, 533 passim. PubMed ID: 10260199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What is the most difficult DUE your P&T Committee has ever conducted? How did you overcome its obstacles?
    Matanin D
    Hosp Formul; 1992 Feb; 27(2):197-8. PubMed ID: 10116718
    [No Abstract]   [Full Text] [Related]  

  • 36. Rational drug use (II): Hospital drug and therapeutics committees.
    Manyemba J; Dzuda C; Nyazema NZ
    Cent Afr J Med; 2000 Sep; 46(9):256-9. PubMed ID: 11320773
    [No Abstract]   [Full Text] [Related]  

  • 37. Formulary management to reduce cost: P & T committee strategies.
    Roberts MJ; Summerfield MR
    Hosp Formul; 1986 Apr; 21(4):481-3, 488-92. PubMed ID: 10276289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An inside look at the UCLA P&T committee: how does it influence prescribing practices?
    Conolly ME
    Hosp Formul; 1986 Feb; 21(2):214-7. PubMed ID: 10275576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. P & T Committee roundtable discussion: Eastern region. Part I.
    Fine DJ; Guild RT; Kleinmann K; Kupersmith J
    Hosp Formul; 1984 Jun; 19(6):469-72, 475-6. PubMed ID: 10266565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma protein fraction and albumin use: the effect of medical staff education.
    Brown RO; Sykes TR; Miller WA; Crowe LR
    Hosp Formul; 1986 May; 21(5):599-606, 616. PubMed ID: 10277579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.